ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Internal Medicine

Top Internal Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSEPH CHI MD

Internal Medicine

16,960

$1.49M

641
491 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$88
Average prescription price

Avg: $56

MANUEL SUAREZ BARCELO MD

Internal Medicine

19,671

$1.48M

593
493 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$75
Average prescription price

Avg: $56

PHILIP ATIGRE MD

Internal Medicine

26,759

$1.48M

737
628 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $56

RALPH PAGE M.D.

Internal Medicine

24,569

$1.48M

601
345 are 65+

42%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $56

MICHAEL FORSTHOEFEL M.D.

Internal Medicine

22,489

$1.47M

764
696 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

CARLOS ROMERO M.D.

Internal Medicine

29,377

$1.47M

1217
878 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $56

JOSE LOPEZ M.D

Internal Medicine

19,863

$1.44M

623
455 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $56

DAVID HEVERT MD

Internal Medicine

13,841

$1.43M

1047
991 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 25%

$103
Average prescription price

Avg: $56

IAN BOYKIN MD

Internal Medicine

21,576

$1.42M

1240
1064 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

AIDA CASTRO M.D.

Internal Medicine

26,274

$1.42M

790
678 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $56

CARLOS VALLEJO M.D. P.A.

Internal Medicine

19,458

$1.42M

444
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 25%

$73
Average prescription price

Avg: $56

BRADLEY TAN M.D.

Internal Medicine

24,507

$1.42M

1250
1024 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $56

RIGOBERTO FRANCO MD

Internal Medicine

20,254

$1.41M

536
397 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $56

SCOTT HALL M.D.

Internal Medicine

5,227

$1.41M

382
162 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 25%

$270
Average prescription price

Avg: $56

ALEJANDRO CINTAS M.D.

Internal Medicine

18,937

$1.41M

556
469 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $56

MANUEL OJEDA MD

Internal Medicine

20,682

$1.4M

520
445 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $56

MALLESWARI RAVI M.D.

Internal Medicine

2,517

$1.39M

121
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

66%
prescriptions for brand name drugs

Avg: 25%

$552
Average prescription price

Avg: $56

REINALDO CARVAJAL M.D.

Internal Medicine

26,961

$1.39M

577
524 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $56

PANKAJ JOSHI MD

Internal Medicine

23,711

$1.38M

542
391 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $56

MANUEL GARCIA-HERRAN MD

Internal Medicine

20,642

$1.37M

1249
1101 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

RAJENDRA BELLAM M.D

Internal Medicine

19,069

$1.36M

667
484 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $56

ISMAIL ZABIH M.D.

Internal Medicine

18,118

$1.36M

712
517 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

29%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$75
Average prescription price

Avg: $56

BETH BRAVER M.D.

Internal Medicine

23,889

$1.36M

1122
850 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $56

ADELA MATTIAZZI MD

Internal Medicine

1,083

$1.36M

110
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 25%

$1254
Average prescription price

Avg: $56

RICARDO CALONGE M.D.

Internal Medicine

22,608

$1.36M

761
722 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank